Letrozole compared with tamoxifen as initial adjuvant therapy for breast cancer

被引：1
|
作者：
Buzdar, Aman U. [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 15期
关键词：
D O I：
10.1200/JCO.2007.11.2755
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2147 / 2148
页数：2
相关论文
共 50 条
  • [1] Letrozole compared with tamoxifen as initial adjuvant therapy for breast cancer - Reply
    Coates, Alan S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (15) : 2148 - 2148
  • [2] Cost effectiveness analysis of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive breast cancer
    Hashem, I.
    Al-Sherbini, M.
    El-Bary, N. Abd
    Swiha, M.
    [J]. BREAST, 2009, 18 : S78 - S78
  • [3] Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer:: Update of study BIG 1-98
    Coates, Alan S.
    Keshaviah, Aparna
    Thuerlimann, Beat
    Mouridsen, Henning
    Mauriac, Louis
    Forbes, John F.
    Paridaens, Robert
    Castiglione-Gertsch, Monica
    Gelber, Richard D.
    Colleoni, Marco
    Lang, Istvan
    Del Mastro, Lucia
    Smith, Ian
    Chirgwin, Jacquie
    Nogaret, Jean-Marie
    Pienkowski, Tadeusz
    Wardley, Andrew
    Jakobsen, Erik H.
    Price, Karen N.
    Goldhirsch, Aron
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) : 486 - 492
  • [4] Adherence to adjuvant endocrine therapy for breast cancer: women's experiences of taking tamoxifen, letrozole and anastrozole
    Harrow, A.
    Dryden, R.
    McCowan, C.
    Radley, A.
    Parsons, M.
    Thompson, A. M.
    Wells, M.
    [J]. EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2014, 18 : S12 - S13
  • [5] Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer
    Mouridsen, Henning
    Giobbie-Hurder, Anita
    Goldhirsch, Aron
    Thuerlimann, Beat
    Paridaens, Robert
    Smith, Ian
    Mauriac, Louis
    Forbes, John F.
    Price, Karen N.
    Regan, Meredith M.
    Gelber, Richard D.
    Coates, Alan S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (08): : 766 - 776
  • [6] Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
    Holm Eggemann
    Atanas Ignatov
    Bobbie J. Smith
    Udo Altmann
    Gunter von Minckwitz
    Freidrich W. Röhl
    Mark Jahn
    Serban-Dan Costa
    [J]. Breast Cancer Research and Treatment, 2013, 137 : 465 - 470
  • [7] Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients
    Eggemann, Holm
    Ignatov, Atanas
    Smith, Bobbie J.
    Altmann, Udo
    von Minckwitz, Gunter
    Roehl, Freidrich W.
    Jahn, Mark
    Costa, Serban-Dan
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2013, 137 (02) : 465 - 470
  • [8] Endocrine effects of adjuvant letrozole plus triptorelin compared with tamoxifen plus triptorelin in premenopausal patients with early breast cancer
    Rossi, Emanuela
    Morabito, Alessandro
    De Maio, Ermelinda
    Di Rella, Francesca
    Esposito, Giuseppe
    Gravina, Adriano
    Labonia, Vincenzo
    Landi, Gabriella
    Nuzzo, Francesco
    Pacilio, Carmen
    Piccirillo, Maria Carmela
    D'Aiuto, Giuseppe
    D'Aiuto, Massimiliano
    Rinaldo, Massimo
    Botti, Gerardo
    Gallo, Ciro
    Perrone, Francesco
    De Matteis, Andrea
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (02) : 264 - 270
  • [9] Letrozole or tamoxifen in early breast cancer
    Erban, JK
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (14): : 1529 - 1529
  • [10] Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone-receptor positive postmenopausal women with early breast cancer.
    Delea, T. E.
    Karnon, J.
    Sofrygin, O.
    Thomas, S. K.
    Barghout, V
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S116 - S117
12345